Seoul, South Korea

Jae Seon Park

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Jae Seon Park

Introduction

Jae Seon Park is an innovative inventor based in Seoul, South Korea. He has contributed significantly to the field of neuroscience through his research and development of novel pharmaceutical compounds. With a focus on glutamate receptors, his work aims to address various neurological disorders and diseases.

Latest Patents

Jae Seon Park holds a patent for "Subunit-selective nucleic acid inhibitors of glutamate receptors." This patent discloses the identification of RNA inhibitors, or aptamers, developed through an in vitro evolution approach. These inhibitors are designed to selectively target AMPA-type glutamate ion channels, essential for understanding their structure and function. The invention highlights an aptamer that acts as a noncompetitive inhibitor of the GluA2QAMPA receptor subunit, showcasing a preference for inhibiting its closed-channel state over other receptor subunits, making it a promising candidate for drug development.

Career Highlights

Jae Seon Park is a part of the State University of New York, where his research continues to break new ground in the understanding of glutamate receptor functions. His contributions to the development of highly potent GluA2 subunit-selective drugs underscore his commitment to advancing therapeutic options for neurological conditions.

Collaborations

In his research endeavors, Jae Seon Park collaborates with notable colleagues such as Li Niu and Zhen Qiu Huang. Their combined expertise enhances the innovative potential of their work, leading to groundbreaking discoveries in the realm of neuroscience and biotechnology.

Conclusion

Jae Seon Park exemplifies the spirit of innovation in the scientific community. His work on subunit-selective nucleic acid inhibitors promises significant advancements in neurological drug development, providing hope for effective treatments for complex disorders. His contributions not only reflect his individual brilliance but also the collaborative efforts within his research institution.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…